NCT01484691View on ClinicalTrials.gov

Role of microRNAs in T Cell-Driven Inflammation in Asthma

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Asthma
Interventions
DRUG

Budesonide

Inhaled powder of inhaled corticosteroid, 1 puff (180mcg) twice a day for 8-10 weeks

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of California, San Francisco

OTHER

NCT01484691 - Role of microRNAs in T Cell-Driven Inflammation in Asthma | Biotech Hunter | Biotech Hunter